Jean-Paul St-Pierre
Geen lopende functies
Oorsprong van het eerstegraads netwerk van Jean-Paul St-Pierre
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Ambrilia Biopharma, Inc.
 Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada.
8
| Private Company | Pharmaceuticals: Major | 8 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jean-Paul St-Pierre via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| University of Sherbrooke | College/University | Graduate Degree | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Ascletis Xinnuo Medicine Co., Ltd | Chief Executive Officer | ||
| Ascletis Pharma China Co., Ltd. | Director/Board Member | ||
| Ascletis BioScience Co., Ltd. | Chief Executive Officer | ||
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member | |
| ASCLETIS PHARMA INC. | Biotechnology | Chief Executive Officer | |
| The BayHelix Group | Corporate Officer/Principal | ||
| SANOFI INDIA LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Corporate Officer/Principal | |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Medical Specialties | Chief Executive Officer | |
| Gannex Pharma Co Ltd. | Chief Executive Officer | ||
| NANOBIOTIX | Medical Specialties | Corporate Officer/Principal | |
| NEOVACS | Pharmaceuticals: Major | Director/Board Member | |
PrimeBioTech
 PrimeBioTech Medical DistributorsDistribution Services PrimeBioTech develops therapeutic products based on gene therapy technologies. The private company is based in Paris, France. | Medical Distributors | President | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
Apicap SAS
 Apicap SAS Investment ManagersFinance Apicap SAS is a Venture Capital firm, a subsidiary of OTC Holding SAS founded in 2001. Apicap SAS is headquartered in Paris. | Investment Managers | Private Equity Investor | |
Solem SAS
 Solem SAS Industrial MachineryProducer Manufacturing Solem SAS manufactures hardware materials. It specializes in hoisting and handling equipment. The company was founded on July 21, 1987 and is headquartered in Epinay-sur-Seine, France. | Industrial Machinery | Director/Board Member | |
| Pets Health Pty Ltd. | Director/Board Member | ||
W SAS
 W SAS Internet Software/ServicesTechnology Services W SAS owns and operates an online portal for e-greetings. It offers a collection of e-greetings for festivals, wishes, entertainment, sentiments, cultures, and other situations. The company was founded by Dany Rafik Smati and is headquartered in Puteaux, France. | Internet Software/Services | Director/Board Member | |
| Soundridge Pharmaceuticals (Hong Kong) Co., Ltd. | Director/Board Member | ||
| Gannex LLC | Corporate Officer/Principal | ||
BIOBank SA
 BIOBank SA Medical/Nursing ServicesHealth Services BIObank SA engages in human tissue development. It prepares, preserves, distributes, and transfers tissues for therapeutic human use. The company was founded by Philippe Chaix, Pierre Lory, and William Gazi on November 4, 1999 and is headquartered in Lieusaint, France. | Medical/Nursing Services | Director/Board Member | |
| ADHERA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Cognisense | Director/Board Member | ||
| Cite Des Biotechs De Laval | Director/Board Member | ||
Autotelic, Inc.
 Autotelic, Inc. Pharmaceuticals: MajorHealth Technology Autotelic, Inc. manufactures therapeutics drugs. Its Therapeutic Drug Monitoring (TDM) device which allows PK guided dosing, reducing the toxicity from overmedication and increasing the efficacy from under-medication. The company was founded in 2013 and is headquartered in Costa Mesa, CA. | Pharmaceuticals: Major | Director/Board Member | |
Isarna Therapeutics BV
 Isarna Therapeutics BV Financial ConglomeratesFinance Isarna Therapeutics BV is an investment holding Dutch company. The private company is based in Zevenbergen, Netherlands. | Financial Conglomerates | Chief Executive Officer | |
| Phileas Pharma, Inc. | Founder | ||
MatriSys Bioscience, Inc.
 MatriSys Bioscience, Inc. BiotechnologyHealth Technology MatriSys Bioscience, Inc. engages in the development of biologic therapeutics. It offers therapies for dermatology and skin care conditions including atopic dermatitis, rosacea, psoriasis, acne, and skin infections. The company was founded by Mark S. Wilson and Richard L. Gallo in 2015 and is headquartered in La Jolla, CA. | Biotechnology | Chief Executive Officer | |
| TRANSCODE THERAPEUTICS, INC. | Biotechnology | Chairman | |
Neurochem (International) Ltd.
 Neurochem (International) Ltd. Miscellaneous Commercial ServicesCommercial Services Neurochem (International) Ltd. provides licensing and partnering activities. Its services include supply chain management and sales, clinical, and regulatory & marketing functions required to develop products. Neurochem is headquartered in Lausanne, Switzerland. | Miscellaneous Commercial Services | President | |
| COHBAR, INC. | Biotechnology | Chief Executive Officer | |
Univalor, Inc.
 Univalor, Inc. Miscellaneous Commercial ServicesCommercial Services Univalor, Inc. engages in the provision of research and development services. The company was founded on April 27, 2001 and is headquartered in Montréal, Canada. | Miscellaneous Commercial Services | Chief Executive Officer | |
PhageTech, Inc.
 PhageTech, Inc. Miscellaneous Commercial ServicesCommercial Services PhageTech, Inc. provides medical services. The firm develops bacteriophage sensors related tests for detecting analytes in urine, blood, and other body fluids. Its technology is used for advanced diagnostics, such as early stage cancer detection, drug dosage monitoring, and time sensitive diseases and conditions. The company was founded by Richard W. Henson, Gregory Weiss, and Reginald Penner in 2014 and is headquartered in Irvine, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Université François-Rabelais de Tours | College/University | Doctorate Degree | |
Servier Canada, Inc.
 Servier Canada, Inc. Pharmaceuticals: MajorHealth Technology Servier Canada, Inc. provides healthcare services. It manufactures pharmaceuticals for cardiology, diabetes, depression, venous disease and menopause. The company was founded in 1978 and is headquartered in Quebec, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
| BELLUS HEALTH | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Ascletis Pharmaceuticals Co., Ltd. | Corporate Officer/Principal | ||
| University of Arizona | College/University | Doctorate Degree | |
| Nanjing University | College/University | Graduate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| ACROPOLIS TELECOM | Specialty Telecommunications | Director/Board Member | |
Rfas 4
 Rfas 4 Financial ConglomeratesFinance Rfas 4 functions as an investment holding French company. The private company is based in Paris, France. and has subsidiaries in France. | Financial Conglomerates | Chairman | |
| THERATECHNOLOGIES INC. | Pharmaceuticals: Major | Chief Executive Officer |
Statistieken
Internationaal
| Verenigde Staten | 17 |
| Frankrijk | 14 |
| Canada | 8 |
| China | 8 |
| Zwitserland | 3 |
Sectoraal
| Health Technology | 21 |
| Consumer Services | 7 |
| Commercial Services | 5 |
| Finance | 4 |
| Distribution Services | 2 |
Operationeel
| Director/Board Member | 44 |
| Corporate Officer/Principal | 24 |
| Chief Executive Officer | 16 |
| Chairman | 14 |
| President | 13 |
Sterkste connecties
| Insiders | |
|---|---|
| Chandrakant Panchal | 22 |
| Jinzi Wu | 20 |
| François Lombard | 19 |
| Philippe Calais | 18 |
| Richard la Rue | 9 |
| Monique Létourneau | 7 |
| Paul-Henry Schmelck | 7 |
| Luc Tanguay | 4 |
- Beurs
- Insiders
- Jean-Paul St-Pierre
- Bedrijfsconnecties
